CD262, Human (Drozitumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD262, Human (Drozitumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD262, Human (Drozitumab biosimilar)
CloneDrozitumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD262 Recombinant Antibody (Drozitumab). Drozitumab is a human monoclonal antibody in development for the treatment of cancers. It targets Tumour Necrosis Factor Related Apoptosis-inducing Ligand (TRAIL), whose receptors are found on the surface of many types of malignant cells. Drozitumab was developed by Genentech. Although drozitumab was studied in phase II trials for treating chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer, development has been halted due to lack of clinical response.
Immunogenn/a
Other NamesAnti-CD262 Recombinant Antibody, Research Grade Drozitumab, Anti-Human CD262 Recombinant Antibody(Drozitumab), PRO95780, anti-DR5, rhuMAb DR5, Antibody Drug Analogues, Monoclonal Antibody, YR1229, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 912628-39-8
Catalog #YR1229
Priceplease inquire
Order / More InfoCD262, Human (Drozitumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.